SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Uflex soars with its arm securing US patent covering entire categories of Formable Films

04 Dec 2018 Evaluate

Uflex is currently trading at Rs. 292.30, up by 13.55 points or 4.86% from its previous closing of Rs. 278.75 on the BSE.

The scrip opened at Rs. 289.40 and has touched a high and low of Rs. 297.00 and Rs. 287.00 respectively. So far 14042 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 506.75 on 26-Dec-2017 and a 52 week low of Rs. 245.40 on 28-Jun-2018.

Last one week high and low of the scrip stood at Rs. 297.00 and Rs. 270.70 respectively. The current market cap of the company is Rs. 2125.18 crore.

The promoters holding in the company stood at 44.02%, while Institutions and Non-Institutions held 10.74% and 45.25% respectively.

Uflex’s global film manufacturing subsidiary -- FlexFilms has been granted United States Patent covering entire categories of Formable Films that include one or more BOPET layers used in Alu Alu blister packaging. The patent US 10131122 was issued to Flex Films (USA) Inc on November 20, 2018 for a period of 20 years. With the patent issuance, the company gets exclusive right of manufacturing & sale of this special BOPET film in US, Europe and India.

This patent has a uniqueness of forming characteristic of BOPET film in Z direction during packaging application.

Uflex is India’s largest multinational flexible packaging materials and Solution Company and an emerging global player. Since its inception back in 1985, Uflex has grown from strength to strength to evolve as a truly Indian Multinational with consumers spread across the world.

Uflex Share Price

406.10 3.80 (0.94%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Uflex 406.10
EPL 233.25
AGI Greenpac 585.45
Huhtamaki India 190.40
TCPL Packaging 2647.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×